Lupin share news and announcements
NSE: LUPINBSE: 500257Pharmaceuticals & BiotechnologyMid Cap
Last close ₹1,928.90up ₹6.90 (0.36%)BSE ₹1,925.00
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,922.00.
52-week range of traded prices to 23 Oct 2026
₹1,892.90Low, 23 Oct 2026₹2,529.50High, 16 Jul 2026
- Next results date: the board meets on 3 Nov 2026 to consider: financial results and other business matters.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹88,207 Cr105th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 6 Aug 2026
- 16.0
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹558 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 14.5
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 7 May 2026
- 3.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.93%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 6 Aug 2026
- 27.9%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹558 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 30.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 6 Aug 2026
- 28.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 7 May 2026
- 0.26
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 7,02,15655.7% delivered
Lupin analyst meets
90 filed, newest first. Page 1 of 2.
Oct 2026
19 Oct · Analysts
Sep 2026
8 Sep · Analysts
Aug 2026
10 Aug · Analysts
Jul 2026
22 Jul · Analysts
May 2026
25 May · Analysts
Apr 2026
23 Apr · Analysts
Feb 2026
19 Feb · Analysts
Jan 2026
Nov 2025
10 Nov · Analysts
Oct 2025
Sep 2025
Aug 2025
27 Aug · Analysts
Jul 2025
Jun 2025
May 2025
Feb 2025
19 Feb · Analysts
Jan 2025
Nov 2024
Oct 2024
Sep 2024
Jul 2024
Apr 2024
Jan 2024
24 Jan · Analysts
Oct 2023
31 Oct · Analysts
Jul 2023
Apr 2023
Jan 2023
8 Jan · Analysts
Oct 2022
Jul 2022
May 2022
Jan 2022
Oct 2021
Aug 2021
Jul 2021
May 2021
Feb 2021
Jan 2021
Oct 2020
Aug 2020
17 Aug · Analysts
Jul 2020